Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks + MK0826, /Duration of Treatment : 8 Weeks + Comparator: metronidazole / Duration of Treatment: 8 Weeks
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Intra-abdominal Infection
Conditions
Intra-abdominal Infection
Trial Timeline
Dec 1, 2001 → Jun 1, 2003
NCT ID
NCT00481702About Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks + MK0826, /Duration of Treatment : 8 Weeks + Comparator: metronidazole / Duration of Treatment: 8 Weeks
Comparator: ceftriaxone sodium / Duration of Treatment: 8 Weeks + MK0826, /Duration of Treatment : 8 Weeks + Comparator: metronidazole / Duration of Treatment: 8 Weeks is a phase 3 stage product being developed by Merck for Intra-abdominal Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00481702. Target conditions include Intra-abdominal Infection.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00481702 | Phase 3 | Completed |
Competing Products
20 competing products in Intra-abdominal Infection